BFRGW — BullFrog AI Holdings, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1829247 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 63,578 | 10,036 | -2,051,769 | -2,011,881 | 5,794,554 | 4,989,914 | 719,310 |
| Jun 2026 | 215,385 | 106,899 | -1,419,061 | -1,371,530 | 7,693,852 | 6,918,141 | 706,590 |
| Mar 2026 | 0 | 0 | -1,614,627 | -1,593,161 | 5,538,863 | 5,080,463 | 652,072 |
| Dec 2025 | 0 | 0 | -1,498,660 | -1,480,174 | 2,808,351 | 2,183,705 | 672,022 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,499,495
Investing CF
$0
Financing CF
$9,944,001
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-26,256,315
Inventory
—
Receivables
$215,385
ST Investments
—
EBIT TTM
$-5,990,957
Pretax Income TTM
$-5,996,477
Interest Exp TTM
$5,520
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 116,670 | -6,594,636 | -6,498,068 | 2,808,351 | 672,022 | 2,136,329 | -5,522,265 |
| Dec 2024 | 0 | -7,236,383 | -6,993,647 | 5,551,830 | 588,090 | 4,963,740 | -5,610,249 |
| Dec 2023 | 65,000 | -5,367,524 | -5,355,869 | 2,776,586 | 184,350 | 2,592,236 | -6,001,299 |
| Dec 2022 | 10,000 | -2,455,801 | -2,802,487 | 80,369 | 3,137,721 | -3,057,352 | -910,890 |
TTM Snapshot
Revenues TTM
$315,187
NetIncome TTM
$-5,996,477
OpCashFlow TTM
—
Assets (Latest)
$7,693,852
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.26T | $1415.55 | — |
| JNJ | JOHNSON & JOHNSON | $670.92B | $278.70 | — |
| ABBV | AbbVie Inc. | $517.59B | $292.82 | — |
| MRK | Merck & Co., Inc. | $353.44B | $143.37 | — |
| NVS | NOVARTIS AG | $302.46B | $159.13 | — |
News headlines (Yahoo Finance, 1h cache)
BullFrog AI Announces Participation at AACR Annual Meeting
2026-04-14 11:30 · Yahoo
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
2026-04-13 11:30 · Yahoo
BullFrog AI issues shareholder letter highlighting recent progress, outlook
2026-04-13 21:29 · Yahoo
Bullfrog AI Holdings Inc. (BFRG) Reports Q3 Loss, Lags Revenue Estimates
2026-11-13 21:25 · Yahoo
Assembly Biosciences (ASMB) Reports Q3 Loss, Lags Revenue Estimates
2026-11-12 21:15 · Yahoo
Carlsmed, Inc. (CARL) Reports Q3 Loss, Tops Revenue Estimates
2026-11-10 21:40 · Yahoo
BullFrog AI Founder and CEO Vin Singh to Deliver Keynote at AIDDD Summit
2026-10-27 12:02 · Yahoo
BullFrog AI to Present at the 20th Annual LD Micro Main Event on October 20, 2026
2026-10-13 12:00 · Yahoo
BullFrog AI Advances Major Depressive Disorder Drug Discovery Program With Global Pharma Partner
2026-10-06 14:39 · Yahoo
BullFrog AI Announces Positive Progress in Drug Discovery Program for Top 5 Global Pharmaceutical in Major Depressive Disorder
2026-10-06 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.